CONSUMER ADVISORY | CA-2025-01

OCM issues consumer advisory for BAK8D brand delta-9 hemp gummies

Product does not meet THC content or labeling requirements

St. Paul, Minn. – The Office of Cannabis Management (OCM) is alerting consumers to avoid consuming the “Oreoz” flavor of BAK8D brand delta-9 tetrahydrocannabinol (THC) gummies due to product mislabeling and THC content above the legal limit. OCM received a report of an adverse health event occurring after consuming the gummies. Testing of the product indicated that levels of THC in an individual gummy were more than 20 times the labeled amount of 5 mg per serving, and the product was not flavored as labeled.

All BAK8D brand delta-9 THC gummies may be affected by this advisory. Products were distributed in Minnesota at retail stores such as tobacco and hemp/CBD stores and may have been sold through internet and retail sales. The affected product flavor was Oreoz but there are four additional flavors manufactured by BAK8D that may be affected.

"It is important that we know when a consumer has a bad experience with a product, so that our enforcement team can determine if there is an ongoing risk to the public," said Eric Taubel, interim director of the Office of Cannabis Management. "This is an important part of responsibility to ensure public health and safety, consumer confidence and market integrity."

These gummies contain 20 times the labeled amount and therefore pose a serious threat to the health of consumers. Consuming more THC than intended could lead to unexpected adverse health effects. Eating cannabis carries a higher risk of overconsuming than smoking it, because it can be difficult to predict the amount that is consumed. Additionally, the onset is slower, and the duration of psychoactive effects is longer. Individuals with existing health conditions may be at a greater risk of experiencing adverse health effects. 

Contact your health care provider or Poison Control at 1-800-222-1222 if you have become ill after consuming BAK8D delta-9 THC gummies. If you have any of the affected products, please discard them and take measures to prevent accidental exposure. Report any adverse events with these products or any other cannabis-derived products to the FDA via MedWatch.

If you have questions about hemp-derived cannabinoid products, visit our Consumer webpage, or email cannabis.info@state.mn.us. If you purchased BAK8D brand gummies and wish to submit a complaint to OCM, a form is available on the Consumer webpage.

###

Having trouble viewing this email? View it as a webpage.